Moreover, a study by Lhomond et al. [167] demonstrated two opposing effects of IRE1α on progression of primary brain tumor, glioblastoma multiform (GBM), depending on activation of XBP1s or RIDD pathways. The gene discussed is ERN1; the disease is glioblastoma.